Pharma

Pharmalot Ed Silverman

Pharmalittle: FDA approves a new wrinkle drug; running remote clinical trials can save pharma money

Pharmalot Ed Silverman

What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency

Pharmalot Ed Silverman

Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever?

Pharmalot Ed Silverman

Pharmalittle: FDA advisers recommend approval of controversial ALS drug; judge rules against coverage of HIV prevention drugs

Pharmalot Ed Silverman

Pharmalittle: FDA holds rare second meeting over an ALS drug; U.S. to expand distribution for monkeypox vaccine

Pharmalot Ed Silverman

Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws

Pharmalot Ed Silverman

Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks

Pharmalot Ed Silverman

Pharmalittle: Illumina deal for Grail is blocked after EU veto; CVS buys Signify to expand into house calls

Pharmalot Jason Mast

Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics

Pharmalot Jonathan Wosen

Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

Pharmalot Jonathan Wosen

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharma Tara Bannow

In a new lawsuit, pharma-backed patient groups fight federal rule around copay coupons

Pharmalot Allison DeAngelis

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

First Opinion Lung-I Cheng

Five years after Kymriah: Ensuring the next cell and gene therapies reach patients

Pharmalot Allison DeAngelis

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Pharmalot Ed Silverman

Centene agrees to pay $33 million to resolve another state probe into its pharmacy benefits business

Pharmalot Ed Silverman

Pharmalittle: House report shows Trump sought to pressure FDA on Covid response; Pfizer Covid pill provides little benefit to younger adults

Pharma Matthew Herper

Pfizer’s experimental RSV vaccine protects older adults in study

Pharmalot Ed Silverman

Pharmalittle: AstraZeneca may exit the vaccine business; Bavarian Nordic looks at expired monkeypox vax doses to boost supplies

Pharmalot Ed Silverman

Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants

Pharmalot Ed Silverman

Major Indian generic drugmaker closes a U.S. facility after years of manufacturing problems

Pharmalot Ed Silverman

Pharmalittle: Murky online market for abortion pills is thriving; more ‘cash pay’ pharmacies decline insurance in the U.S.

Pharmalot Ed Silverman

FDA scolds Sun Pharma for allegedly backdating documents and fudging records for collecting drug samples

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalittle: Biden plan to shift cost of Covid-19 products to consumers; U.S. company to help with monkeypox shot production

Pharmalot Ed Silverman

Medicare may eventually negotiate some drug prices, but Colorado still wants to import medicines from Canada

Pharmalot Ed Silverman

Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisis